Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Chemin

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
The Lancet. Global Health|July 30, 2023
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort studyGibril Ndow, Erwan Vo-Quang, Yusuke Shimakawa, et al.
Hepatitis Research and Treatment|July 16, 2011
Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from ThailandOlivier Galy, Isabelle Chemin, Emilie Le Roux, et al.
IJID Regions|February 3, 2025
Prevalence and molecular characterization of hepatitis delta virus infection among hepatitis B virus surface antigen positive students and pregnant women in N'djamena, ChadNalda Debsikréo, Maire Dehainsala, Odan Debsikréo, et al.
Hepatology International|May 30, 2019
Alteration of splicing factors' expression during liver disease progression: impact on hepatocellular carcinoma outcomeHualin Wang, Bouchra Lekbaby, Nadim Fares, et al.
Clinics and Research in Hepatology and Gastroenterology|August 24, 2020
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in SenegalRayana Maryse Toyé, Gora Lô, Halimatou Diop-Ndiaye, et al.
Clinics and Research in Hepatology and Gastroenterology|November 13, 2020
PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?Laetitia Gerossier, Anaëlle Dubois, Alexia Paturel, et al.
IJID Regions|October 14, 2024
Triple burden of hepatitis B, hepatitis Delta viruses, and <i>Plasmodium falciparum</i> to pregnant womenAude Sandrine Andeme Eyi, Opheelia Makoyo Komba, Claire Chambellant, et al.
Medecine Sciences : M/S|May 23, 2019
[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]Damien Cohen, Yusuke Shimakawa, Gibril Ndow, et al.
Journal of Hepatology|May 23, 2024
Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytesFleur Chapus, Guillaume Giraud, Pélagie Huchon, et al.
Frontiers in Cellular and Infection Microbiology|September 20, 2023
Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populationsArmando Andres Roca Suarez, Séverine Planel, Xavier Grand, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
The Lancet. Global Health|July 30, 2023
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort studyGibril Ndow, Erwan Vo-Quang, Yusuke Shimakawa, et al.
Hepatitis Research and Treatment|July 16, 2011
Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from ThailandOlivier Galy, Isabelle Chemin, Emilie Le Roux, et al.
IJID Regions|February 3, 2025
Prevalence and molecular characterization of hepatitis delta virus infection among hepatitis B virus surface antigen positive students and pregnant women in N'djamena, ChadNalda Debsikréo, Maire Dehainsala, Odan Debsikréo, et al.
Hepatology International|May 30, 2019
Alteration of splicing factors' expression during liver disease progression: impact on hepatocellular carcinoma outcomeHualin Wang, Bouchra Lekbaby, Nadim Fares, et al.
Clinics and Research in Hepatology and Gastroenterology|August 24, 2020
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in SenegalRayana Maryse Toyé, Gora Lô, Halimatou Diop-Ndiaye, et al.
Clinics and Research in Hepatology and Gastroenterology|November 13, 2020
PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?Laetitia Gerossier, Anaëlle Dubois, Alexia Paturel, et al.
IJID Regions|October 14, 2024
Triple burden of hepatitis B, hepatitis Delta viruses, and <i>Plasmodium falciparum</i> to pregnant womenAude Sandrine Andeme Eyi, Opheelia Makoyo Komba, Claire Chambellant, et al.
Medecine Sciences : M/S|May 23, 2019
[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]Damien Cohen, Yusuke Shimakawa, Gibril Ndow, et al.
Journal of Hepatology|May 23, 2024
Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytesFleur Chapus, Guillaume Giraud, Pélagie Huchon, et al.
Frontiers in Cellular and Infection Microbiology|September 20, 2023
Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populationsArmando Andres Roca Suarez, Séverine Planel, Xavier Grand, et al.
Pageof 8